Dysnatremias in the intensive care unit

Area of Science:

• Critical Care Medicine
• Nephrology
• Internal Medicine

Background:

• Dysnatremia, including hyponatremia and hypernatremia, affects 20-30% of intensive care unit (ICU) patients.
• Both hypo- and hypernatremia on ICU admission or during the stay are independent risk factors for poor prognosis.
• Hypernatremia often results from iatrogenic causes like inadequate free water replacement, while hyponatremia involves complex factors including arginine vasopressin dysregulation and hypotonic fluid administration.

Purpose of the Study:

• To review the prevalence, risk factors, and management strategies for dysnatremias in critically ill patients.
• To highlight the importance of serial electrolyte monitoring and discuss therapeutic options for severe hypo- and hypernatremia.

Main Methods:

• Literature review focusing on recent data and established therapeutic guidelines for dysnatremia management in the ICU.
• Discussion of diagnostic and therapeutic approaches, including the use of hypertonic saline and vasopressin receptor antagonists.

Main Results:

• Both hypo- and hypernatremia are independent predictors of adverse outcomes in ICU patients.
• Standard formulae for correction may not account for variable fluid losses, emphasizing the need for serial monitoring.
• Hypertonic saline is effective for hyponatremic encephalopathy, and vasopressin receptor antagonists offer another therapeutic avenue for hyponatremia.

Conclusions:

• Effective management of dysnatremia is imperative in critically ill patients due to its association with morbidity and mortality.
• Proper correction of hyponatremia is linked to improved short- and long-term patient outcomes.